Abstract
Lead identification and optimisation have evolved into multidimensional, multidisciplinary and information-driven processes. Herein, we review the contribution of computational chemistry to these processes. We focus on computational approaches developed for modelling biopharmaceutical properties, including in vitro activity, selectivity, absorption, distribution, metabolism, excretion and toxicity. Whenever possible, successful applications are mentioned.
Keywords: lead discovery, lead optimisation, molecular descriptors, pharmacophores, quantitative structure-activity relationships
Combinatorial Chemistry & High Throughput Screening
Title: Computational Methods for the Identification and Optimisation of High Quality Leads
Volume: 7 Issue: 4
Author(s): Bernard Pirard
Affiliation:
Keywords: lead discovery, lead optimisation, molecular descriptors, pharmacophores, quantitative structure-activity relationships
Abstract: Lead identification and optimisation have evolved into multidimensional, multidisciplinary and information-driven processes. Herein, we review the contribution of computational chemistry to these processes. We focus on computational approaches developed for modelling biopharmaceutical properties, including in vitro activity, selectivity, absorption, distribution, metabolism, excretion and toxicity. Whenever possible, successful applications are mentioned.
Export Options
About this article
Cite this article as:
Pirard Bernard, Computational Methods for the Identification and Optimisation of High Quality Leads, Combinatorial Chemistry & High Throughput Screening 2004; 7 (4) . https://dx.doi.org/10.2174/1386207043328643
DOI https://dx.doi.org/10.2174/1386207043328643 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Toll-like Receptor 4 Mediates LPS-Induced Release of Nitric Oxide and Tumor Necrosis Factor-α by Embryonal Cardiomyocytes: Biological Significance and Clinical Implications in Human Pathology
Current Pharmaceutical Design Applications of Fractal and Non-linear Time Series Analysis to the Study of Short-term Cardiovascular Control
Current Vascular Pharmacology Angiotensin-(1-7): Blood, Heart, and Blood Vessels
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Biocatalysis in the Pharmaceutical Industry. A Greener Future
Current Green Chemistry Evaluation of Electromyogram Signals in the Control of Prosthetic Limb: A Review
Current Signal Transduction Therapy Patents in the Diagnosis and Therapy of Neurocardiogenic Syncope
Recent Patents on Cardiovascular Drug Discovery Role of Ca2+-Sensitive K+ Currents in Controlling Ventricular Repolarization: Possible Implications for Future Antiarrhytmic Drug Therapy
Current Medicinal Chemistry The Proteasome in Health and Disease
Current Pharmaceutical Design Editorial [Hot topic: Drug-Induced QT Interval Prolongation: Clinical, Safety and Regulatory Update (Guest Editor: Guillermo Di Girolamo)]
Current Drug Safety Acetaminophen (Paracetamol) and Injury in the Cardiovascular System
Vascular Disease Prevention (Discontinued) Pharmacological Prevention of Peri-, and Post-Procedural Myocardial Injury in Percutaneous Coronary Intervention
Current Cardiology Reviews Blockade of Apoptosis by ACE Inhibitors and Angiotensin Receptor Antagonists
Current Pharmaceutical Design Obesity Pharmacotherapy: Current Perspectives and Future Directions
Current Cardiology Reviews The Na+/H+ Exchanger: A Target for Cardiac Therapeutic Intervention
Current Drug Targets - Cardiovascular & Hematological Disorders Natural Products as a Source of Antiarrhythmic Drugs
Mini-Reviews in Medicinal Chemistry Cardioprotection by Targeting the Pool of Resident and Extracardiac Progenitors
Current Drug Targets Xanthine Derivatives in the Heart: Blessed or Cursed?
Current Medicinal Chemistry Management of Hypertension in Relation to Acute Coronary Syndromes and Revascularisation
Current Pharmaceutical Design Connexin Modulators and Their Potential Targets under the Magnifying Glass
Current Medicinal Chemistry Primary Prevention of Ischaemic Stroke in Atrial Fibrillation: New Oral Anticoagulant Drugs for all?
Current Vascular Pharmacology